Bay Colony Advisory Group, Inc D Novo Nordisk A S Transaction History
Bay Colony Advisory Group, Inc D
- $643 Million
- Q4 2024
A detailed history of Bay Colony Advisory Group, Inc D transactions in Novo Nordisk A S stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 10,754 shares of NVO stock, worth $870,858. This represents 0.14% of its overall portfolio holdings.
Number of Shares
10,754
Previous 13,677
21.37%
Holding current value
$870,858
Previous $1.63 Million
43.18%
% of portfolio
0.14%
Previous 0.26%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,885Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.62 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.25 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.05 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.02 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$988 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $183B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...